You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

NHS IL-12

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Kaposi Sarcoma Trial run by the NCI (NHS-IL12, M7824)

Recruiting
  • Kaposi Sarcoma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 25, 2023

Anatomic Stage IV Breast Cancer AJCC v8, Hormone Receptor Positive Breast Adenocarcinoma, Metastatic Breast Carcinoma Trial in

Withdrawn
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +4 more
  • Bintrafusp Alfa
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 2, 2022

Cancer, Solid Tumor, Metastatic Checkpoint Refractory HPV Associated Malignancies Trial run by the National Cancer Institute

Recruiting
  • Cancer
  • +3 more
  • Bintrafusp Alfa
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 11, 2022

Urothelial Cancer, Bladder Cancer, Genitourinary Cancer Trial run by the NCI (M7824, M9241, Stereotactic body radiation therapy

Recruiting
  • Urothelial Cancer
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 23, 2023

Epithelial Tumors, Malignant, Epithelial Tumors, Malignant, Malignant Mesenchymal Tumor Trial run by the NCI (NHS-IL-12)

Completed
  • Epithelial Neoplasms, Malignant
  • +2 more
  • NHS-IL-12
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 15, 2021

Cervical Cancer, HPV Cancers, Anal Cancer Trial run by the NCI (PDS0101, M7824, NHS-IL12)

Active, not recruiting
  • Cervical Cancer
  • +4 more
  • PDS0101
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 24, 2023

Small Bowel Cancers, Colorectal Cancers Trial run by the NCI (CV301, MSB0011359C, N-803)

Recruiting
  • Small Bowel Cancers
  • Colorectal Cancers
  • CV301
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jul 6, 2022

Histologically or Cytologically Confirmed Pancreatic Cancer, Unresectable or Borderline Resectable Pancreatic Cancer, Pancreatic

Terminated
Has Results
  • Histologically or Cytologically Confirmed Pancreatic Cancer
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Apr 19, 2022

Advanced Solid Tumors Trial in Worldwide (Avelumab, M9241, Avelumab (Once weekly))

Terminated
  • Advanced Solid Tumors
  • San Diego, California
  • +32 more
Dec 15, 2020

Crohn Disease Trial in Calgary (TNFa Antagonist - Infliximab, TNFa Antagonist - Adalimumab, Anti-IL12/23 or anti-IL23 -

Not yet recruiting
  • Crohn Disease
  • TNFa Antagonist - Infliximab
  • +5 more
  • Calgary, Alberta, Canada
    University of Calgary
Jun 22, 2023

LAD1 Trial run by the NIAID (Ustekinumab)

Recruiting
  • LAD1
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 24, 2023

HIV Trial in South Africa, United States (sD-NP-GT8 DNA, IL-12 DNA, Trimer 4571)

Not yet recruiting
  • HIV Infections
  • sD-NP-GT8 DNA
  • +4 more
  • Birmingham, Alabama
  • +5 more
Mar 10, 2023

Periodontitis Trial (No intervention was applied to the groups the samples will be collected in terms of the diagnosis (

Not yet recruiting
  • Periodontitis
  • No intervention was applied to the groups the samples will be collected in terms of the diagnosis ( periodontitis, healthy)
  • (no location specified)
Mar 31, 2022

Healthy Adult Trial in Melbourne (SON-1010 (IL12-FHAB))

Recruiting
  • Healthy Adult
  • SON-1010 (IL12-FHAB)
  • Melbourne, Victoria, Australia
    Nucleus Network Pty Ltd
Oct 26, 2022

Subarachnoid Hemorrhage Trial in United Kingdom (IL-1Ra, IL-1Ra Placebo)

Recruiting
  • Subarachnoid Hemorrhage
  • Plymouth, Devon, United Kingdom
  • +11 more
May 16, 2022

Advanced Solid Tumor, Platinum-resistant Ovarian Cancer Trial (SON-1010)

Not yet recruiting
  • Advanced Solid Tumor
  • Platinum-resistant Ovarian Cancer
  • SON-1010
  • (no location specified)
Mar 10, 2023

Glioblastoma Multiforme, Anaplastic Astrocytoma, Gliosarcoma Trial in Birmingham (M032, Pembrolizumab)

Recruiting
  • Glioblastoma Multiforme
  • +2 more
  • Birmingham, Alabama
    University of Alabama at Birmingham
Jan 30, 2023

Triple Negative Breast Cancer, Anthracycline-refractory TNBC Trial in Houston (Docetaxel, Pembrolizumab, IL-12 gene therapy)

Suspended
  • Triple Negative Breast Cancer
  • Anthracycline-refractory TNBC
  • Houston, Texas
    Houston Methodist Cancer Center
Mar 28, 2022

Soft Tissue Sarcoma, Bone Sarcoma Trial in Houston (Cyclophosphamide, attIL2-T cells)

Not yet recruiting
  • Soft Tissue Sarcoma
  • Bone Sarcoma
  • Houston, Texas
    M D Anderson Cancer Center
Nov 10, 2022

HIV Trial in United States (PennVax B, IL-12, IL-15)

Completed
  • HIV Infections
  • PennVax B
  • +2 more
  • Birmingham, Alabama
  • +7 more
Oct 13, 2021

Behçet Disease Trial in Paris (Subcutaneous Ustekinumab)

Completed
  • Behçet Disease
  • Subcutaneous Ustekinumab
  • Paris, France
    Hôpital Cochin, Department of Internal Medicine, National Refere
Nov 19, 2021

Solid Tumors Trial in New York (procedure, drug, device, genetic)

Active, not recruiting
  • Solid Tumors
  • Production of Genetically-modified T cells
  • +4 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Sep 1, 2022

Neurological Recovery Following NOS-SACD

Not yet recruiting
  • Nitrous Oxide Abuse
  • +4 more
  • Observational study with no interventions
  • (no location specified)
Feb 2, 2023

Intracerebral Haemorrhage Trial in Manchester (IL-1Ra Kineret®, IL-1Ra Placebo)

Completed
  • Intracerebral Haemorrhage
  • IL-1Ra Kineret®
  • IL-1Ra Placebo
  • Manchester, North West, United Kingdom
    Salford Royal NHS Foundation Trust
Oct 4, 2021

HIV-1-infection Trial in Los Angeles, San Francisco (PENNVAX-GP, INO-6145, INO-9012)

Completed
  • HIV-1-infection
  • PENNVAX-GP
  • +3 more
  • Los Angeles, California
  • +1 more
Apr 4, 2022